Voyager Therapeutics, Inc. (NASDAQ: VYGR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Institutional investors own a significant stake of 48% in Voyager Therapeutics, Inc. (NASDAQ:VYGR) [Yahoo! Finance]
Wall Street Analysts See a 152.53% Upside in Voyager Therapeutics (VYGR): Can the Stock Really Move This High? [Yahoo! Finance]
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $12.00 price target on the stock.
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $11.00 price target on the stock.